Review




Structured Review

AID Diagnostika aid classic elispot reader
ASFV-specific antibody and cellular immune responses: percentage of blocking by p72-specific serum antibodies after mock-immunisation with PBS ( A ) or immunisation with ASFV-Ke-∆EP402R∆A238L ( B ) determined using a commercial blocking ELISA. Mean+/−SEM of percentage blocking in PBS- or ASFV-Ke-∆EP402R∆A238L-immunised groups ( C ). IFNγ <t>ELISPOT</t> using PBMC isolated from animals at day 28 after immunisation with PBS (blue) or ASFV-Ke-∆EP402R∆A238L (red) and stimulation with either medium or ASFV-Ke wild type (wt) infection at an MOI of 0.1 ( D ).
Aid Classic Elispot Reader, supplied by AID Diagnostika, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/aid+classic+elispot+reader/pmc09501025-72-6-11
Average 90 stars, based on 1 article reviews
aid classic elispot reader - by Bioz Stars, 2026-11
90/100 stars

Images

1) Product Images from "Co-Deletion of A238L and EP402R Genes from a Genotype IX African Swine Fever Virus Results in Partial Attenuation and Protection in Swine"

Article Title: Co-Deletion of A238L and EP402R Genes from a Genotype IX African Swine Fever Virus Results in Partial Attenuation and Protection in Swine

Journal: Viruses

doi: 10.3390/v14092024

ASFV-specific antibody and cellular immune responses: percentage of blocking by p72-specific serum antibodies after mock-immunisation with PBS ( A ) or immunisation with ASFV-Ke-∆EP402R∆A238L ( B ) determined using a commercial blocking ELISA. Mean+/−SEM of percentage blocking in PBS- or ASFV-Ke-∆EP402R∆A238L-immunised groups ( C ). IFNγ ELISPOT using PBMC isolated from animals at day 28 after immunisation with PBS (blue) or ASFV-Ke-∆EP402R∆A238L (red) and stimulation with either medium or ASFV-Ke wild type (wt) infection at an MOI of 0.1 ( D ).
Figure Legend Snippet: ASFV-specific antibody and cellular immune responses: percentage of blocking by p72-specific serum antibodies after mock-immunisation with PBS ( A ) or immunisation with ASFV-Ke-∆EP402R∆A238L ( B ) determined using a commercial blocking ELISA. Mean+/−SEM of percentage blocking in PBS- or ASFV-Ke-∆EP402R∆A238L-immunised groups ( C ). IFNγ ELISPOT using PBMC isolated from animals at day 28 after immunisation with PBS (blue) or ASFV-Ke-∆EP402R∆A238L (red) and stimulation with either medium or ASFV-Ke wild type (wt) infection at an MOI of 0.1 ( D ).

Techniques Used: Blocking Assay, Enzyme-linked Immunosorbent Assay, Enzyme-linked Immunospot, Isolation, Infection

Related Articles

Enzyme-linked Immunospot:

Article Title: Ultrasound-mediated delivery of doxorubicin to the brain results in immune modulation and improved responses to PD-1 blockade in gliomas
Article Snippet: .. Data and images of the IFN-γ spots in 96-well plates were acquired using the classic AID EliSpot reader (Autoimmun diagnostika GBMH). ..


Article Title: The survival of B cells is compromised in kidney disease.
Article Snippet: The spots were visualized with AEC substrate (BD Biosciences) for 30min at room temperature in the dark and reaction was stopped by rinsing plateswith distilledwater. .. Themembraneswere airdried and the spots were counted using the AID Classic ELISPOT reader (AID Autoimmun Diagnostika, GMBH). ..

Article Title: Exosomal transfer of HCC-derived miR-17-5p downregulates NK cell function by targeting RUNX1-NKG2D axis.
Article Snippet: Objective: Natural killer (NK) cells are an integral part of the staunch defense line against malignant tumors within the tumor microenvironment.. Existing research indicates that miRNAs can influence the development of NK cells by negatively modulating gene expression.. In this study, we aim to explore how the miR-17-5p in Hepatocellular Carcinoma (HCC) exosomes regulates the killing function of NK cells towards HCC cells through the transcription factor RNX1.

Article Title: Cytosolic protein translation regulates cell asymmetry and function in early TCR activation of human CD8 + T lymphocytes.
Article Snippet: Spots were revealed following the manufacturer’s protocol frontiersin.org (Mabtech, Stockholm, Sweden). .. Enzyme-linked immunosorbent spot (ELISPOT) plates were analysed using an AID classic ELISPOT reader (AID Autoimmun Diagnostika GmbH). .. IFN-g detection by ELISA To study the capacity of CTLs to produce IFN-g after TCR and CD28 co-stimulation, 0.5 × 106 cells per condition were treated with CHX (20 mg/mL), PURO (50 μg/mL), or CTRL for 1 h and then stimulated or not with 10 mL of aCD3/aCD28 antibodies (ImmunoCult Human CD3/CD28 T Cell Activator) for 30 min. Then, supernatant cultures were collected, and cells were lysed in 50 mL of 20 mM Tris-HCl (pH 7.5) containing 1% NP-40, 0.2% Triton X-100, 150 mM NaCl, 2 mM EDTA, and 1.5 mM MgCl2 with phosphatase and protease inhibitor cocktails (Sigma-Aldrich) for 30 min at 4°C.

Article Title: Human effector CD8 + T cells with an activated and exhausted-like phenotype control tumour growth in vivo in a humanized tumour model.
Article Snippet: Findings We found human T cell subsets described in human cancer, including progenitor exhausted (Tpex), terminally exhausted (Tex-term) and tissue-resident (TRM) cells in tumour-bearing humanized mice with accumulation of Tex-term and TRM in the tumour.. In addition, we identified tumour-reactive CD8 + T cells through expression of CD137.. This subpopulation of de novo arising human CD137 CD8 T cells displayed a highly proliferative, fully activated effector and exhausted-like phenotype with enhanced expression of activation and exhaustion markers like PD-1, CD39, CD160, TIM-3, TIGIT and TOX, the senescence marker CD57 (B3GAT1) and cytolytic effector molecules such as PRF1, GZMH and NKG7.

Article Title: The survival of B cells is compromised in kidney disease
Article Snippet: The spots were visualized with AEC substrate (BD Biosciences) for 30 min at room temperature in the dark and reaction was stopped by rinsing plates with distilled water. .. The membranes were airdried and the spots were counted using the AID Classic ELISPOT reader (AID Autoimmun Diagnostika, GMBH). ..

Software:

Article Title: Human effector CD8 + T cells with an activated and exhausted-like phenotype control tumour growth in vivo in a humanized tumour model.
Article Snippet: Findings We found human T cell subsets described in human cancer, including progenitor exhausted (Tpex), terminally exhausted (Tex-term) and tissue-resident (TRM) cells in tumour-bearing humanized mice with accumulation of Tex-term and TRM in the tumour.. In addition, we identified tumour-reactive CD8 + T cells through expression of CD137.. This subpopulation of de novo arising human CD137 CD8 T cells displayed a highly proliferative, fully activated effector and exhausted-like phenotype with enhanced expression of activation and exhaustion markers like PD-1, CD39, CD160, TIM-3, TIGIT and TOX, the senescence marker CD57 (B3GAT1) and cytolytic effector molecules such as PRF1, GZMH and NKG7.

other:

Article Title: Proactive vaccination using multiviral Quartet Nanocages to elicit broad anti-coronavirus responses.
Article Snippet: For calculation of midpoint titre, sigmoidal dose–response curve absorbance data and the midpoint were calculated using GraphPad Prism (GraphPad Software v.9.4.1).



Similar Products

99
Cellular Technology Ltd elispot reader
Im@NOnanoPL nanovaccine mediated enhanced long‐term immune memory in vivo. (A) Schematic illustration to evaluate the therapeutic antitumor effects after different treatments. (B) Flow cytometry analysis of MHC‐I expression and MHC‐I OVA complex levels of DCs in lymph nodes (n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (C) Flow cytometry analysis of CD80 + CD86 + among CD11c + DCs in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (D) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (E) Percentage of CD69 + CD8 + T cells in spleen after 24 h co‐culture with OVA polypeptide, as detected using flow cytometry ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (F) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (G) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD4 + T cells in spleen after 24 h co‐culture with OVA polypeptide. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (H) Schema illustrating the vaccination long‐term immune memory. Mice were challenged with MC38‐OVA cells (3 × 10 5 cells/mouse, s.c.) on day 0. Mice with complete tumor regression were subjected to tumor rechallenge with MC38‐OVA cells (3 × 10 6 cells/mouse, s.c.), and tumor analysis was performed on day 60. (I) Representative flow cytometry images of central T cells and memory T cells in spleen following various treatments. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (J) Flow cytometry analysis of granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 . (K and L) IFN‐𝛾 secretion by splenocytes isolated from different treatment groups, as determined using the <t>ELISPOT</t> assay after restimulation of the cells with OVA 257–264 . (M) Tumor killing ability of the splenocytes isolated T cells activated by OVA 257–264 . After 24 h co‐culture with OVA 257–264 , the T cells were co‐cultured with MC38‐OVA cells at a 3:1 ratio for 24 h, cell viability was measured by CCK‐8 assay. (N) Tumor growth curve following tumor rechallenge and Survival curves of mice under Im@NOnanoPL+αPD‐1 or PBS. ( n = 6).
Elispot Reader, supplied by Cellular Technology Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/ImmunoSpot+Software/pmc13654190-267-7-9
Average 99 stars, based on 1 article reviews
elispot reader - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Cellular Technology Ltd elispot reader ctl s6 entry m2 analyzer
Im@NOnanoPL nanovaccine mediated enhanced long‐term immune memory in vivo. (A) Schematic illustration to evaluate the therapeutic antitumor effects after different treatments. (B) Flow cytometry analysis of MHC‐I expression and MHC‐I OVA complex levels of DCs in lymph nodes (n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (C) Flow cytometry analysis of CD80 + CD86 + among CD11c + DCs in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (D) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (E) Percentage of CD69 + CD8 + T cells in spleen after 24 h co‐culture with OVA polypeptide, as detected using flow cytometry ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (F) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (G) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD4 + T cells in spleen after 24 h co‐culture with OVA polypeptide. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (H) Schema illustrating the vaccination long‐term immune memory. Mice were challenged with MC38‐OVA cells (3 × 10 5 cells/mouse, s.c.) on day 0. Mice with complete tumor regression were subjected to tumor rechallenge with MC38‐OVA cells (3 × 10 6 cells/mouse, s.c.), and tumor analysis was performed on day 60. (I) Representative flow cytometry images of central T cells and memory T cells in spleen following various treatments. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (J) Flow cytometry analysis of granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 . (K and L) IFN‐𝛾 secretion by splenocytes isolated from different treatment groups, as determined using the <t>ELISPOT</t> assay after restimulation of the cells with OVA 257–264 . (M) Tumor killing ability of the splenocytes isolated T cells activated by OVA 257–264 . After 24 h co‐culture with OVA 257–264 , the T cells were co‐cultured with MC38‐OVA cells at a 3:1 ratio for 24 h, cell viability was measured by CCK‐8 assay. (N) Tumor growth curve following tumor rechallenge and Survival curves of mice under Im@NOnanoPL+αPD‐1 or PBS. ( n = 6).
Elispot Reader Ctl S6 Entry M2 Analyzer, supplied by Cellular Technology Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/S6+Entry+M2/10__1038_slash_s41541___026___01527___4-210-14-21
Average 99 stars, based on 1 article reviews
elispot reader ctl s6 entry m2 analyzer - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

86
Mabtech Inc astor elispot reader
Im@NOnanoPL nanovaccine mediated enhanced long‐term immune memory in vivo. (A) Schematic illustration to evaluate the therapeutic antitumor effects after different treatments. (B) Flow cytometry analysis of MHC‐I expression and MHC‐I OVA complex levels of DCs in lymph nodes (n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (C) Flow cytometry analysis of CD80 + CD86 + among CD11c + DCs in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (D) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (E) Percentage of CD69 + CD8 + T cells in spleen after 24 h co‐culture with OVA polypeptide, as detected using flow cytometry ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (F) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (G) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD4 + T cells in spleen after 24 h co‐culture with OVA polypeptide. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (H) Schema illustrating the vaccination long‐term immune memory. Mice were challenged with MC38‐OVA cells (3 × 10 5 cells/mouse, s.c.) on day 0. Mice with complete tumor regression were subjected to tumor rechallenge with MC38‐OVA cells (3 × 10 6 cells/mouse, s.c.), and tumor analysis was performed on day 60. (I) Representative flow cytometry images of central T cells and memory T cells in spleen following various treatments. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (J) Flow cytometry analysis of granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 . (K and L) IFN‐𝛾 secretion by splenocytes isolated from different treatment groups, as determined using the <t>ELISPOT</t> assay after restimulation of the cells with OVA 257–264 . (M) Tumor killing ability of the splenocytes isolated T cells activated by OVA 257–264 . After 24 h co‐culture with OVA 257–264 , the T cells were co‐cultured with MC38‐OVA cells at a 3:1 ratio for 24 h, cell viability was measured by CCK‐8 assay. (N) Tumor growth curve following tumor rechallenge and Survival curves of mice under Im@NOnanoPL+αPD‐1 or PBS. ( n = 6).
Astor Elispot Reader, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/elispot+fluorospot+iris+mabtech+reader/pm42310741-96-14-17
Average 86 stars, based on 1 article reviews
astor elispot reader - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Mabtech Inc iris elispot fluorospot reader
Im@NOnanoPL nanovaccine mediated enhanced long‐term immune memory in vivo. (A) Schematic illustration to evaluate the therapeutic antitumor effects after different treatments. (B) Flow cytometry analysis of MHC‐I expression and MHC‐I OVA complex levels of DCs in lymph nodes (n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (C) Flow cytometry analysis of CD80 + CD86 + among CD11c + DCs in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (D) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (E) Percentage of CD69 + CD8 + T cells in spleen after 24 h co‐culture with OVA polypeptide, as detected using flow cytometry ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (F) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (G) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD4 + T cells in spleen after 24 h co‐culture with OVA polypeptide. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (H) Schema illustrating the vaccination long‐term immune memory. Mice were challenged with MC38‐OVA cells (3 × 10 5 cells/mouse, s.c.) on day 0. Mice with complete tumor regression were subjected to tumor rechallenge with MC38‐OVA cells (3 × 10 6 cells/mouse, s.c.), and tumor analysis was performed on day 60. (I) Representative flow cytometry images of central T cells and memory T cells in spleen following various treatments. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (J) Flow cytometry analysis of granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 . (K and L) IFN‐𝛾 secretion by splenocytes isolated from different treatment groups, as determined using the <t>ELISPOT</t> assay after restimulation of the cells with OVA 257–264 . (M) Tumor killing ability of the splenocytes isolated T cells activated by OVA 257–264 . After 24 h co‐culture with OVA 257–264 , the T cells were co‐cultured with MC38‐OVA cells at a 3:1 ratio for 24 h, cell viability was measured by CCK‐8 assay. (N) Tumor growth curve following tumor rechallenge and Survival curves of mice under Im@NOnanoPL+αPD‐1 or PBS. ( n = 6).
Iris Elispot Fluorospot Reader, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/elispot+fluorospot+iris+mabtech+reader/pmc13260466-90-26-29
Average 86 stars, based on 1 article reviews
iris elispot fluorospot reader - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Mabtech Inc elispot reader
Im@NOnanoPL nanovaccine mediated enhanced long‐term immune memory in vivo. (A) Schematic illustration to evaluate the therapeutic antitumor effects after different treatments. (B) Flow cytometry analysis of MHC‐I expression and MHC‐I OVA complex levels of DCs in lymph nodes (n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (C) Flow cytometry analysis of CD80 + CD86 + among CD11c + DCs in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (D) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (E) Percentage of CD69 + CD8 + T cells in spleen after 24 h co‐culture with OVA polypeptide, as detected using flow cytometry ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (F) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (G) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD4 + T cells in spleen after 24 h co‐culture with OVA polypeptide. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (H) Schema illustrating the vaccination long‐term immune memory. Mice were challenged with MC38‐OVA cells (3 × 10 5 cells/mouse, s.c.) on day 0. Mice with complete tumor regression were subjected to tumor rechallenge with MC38‐OVA cells (3 × 10 6 cells/mouse, s.c.), and tumor analysis was performed on day 60. (I) Representative flow cytometry images of central T cells and memory T cells in spleen following various treatments. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (J) Flow cytometry analysis of granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 . (K and L) IFN‐𝛾 secretion by splenocytes isolated from different treatment groups, as determined using the <t>ELISPOT</t> assay after restimulation of the cells with OVA 257–264 . (M) Tumor killing ability of the splenocytes isolated T cells activated by OVA 257–264 . After 24 h co‐culture with OVA 257–264 , the T cells were co‐cultured with MC38‐OVA cells at a 3:1 ratio for 24 h, cell viability was measured by CCK‐8 assay. (N) Tumor growth curve following tumor rechallenge and Survival curves of mice under Im@NOnanoPL+αPD‐1 or PBS. ( n = 6).
Elispot Reader, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/elispot+fluorospot+iris+mabtech+reader/pm42150061-364-10-12
Average 86 stars, based on 1 article reviews
elispot reader - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

99
Cellular Technology Ltd elispot reader s6 ultra m2
Im@NOnanoPL nanovaccine mediated enhanced long‐term immune memory in vivo. (A) Schematic illustration to evaluate the therapeutic antitumor effects after different treatments. (B) Flow cytometry analysis of MHC‐I expression and MHC‐I OVA complex levels of DCs in lymph nodes (n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (C) Flow cytometry analysis of CD80 + CD86 + among CD11c + DCs in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (D) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (E) Percentage of CD69 + CD8 + T cells in spleen after 24 h co‐culture with OVA polypeptide, as detected using flow cytometry ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (F) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (G) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD4 + T cells in spleen after 24 h co‐culture with OVA polypeptide. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (H) Schema illustrating the vaccination long‐term immune memory. Mice were challenged with MC38‐OVA cells (3 × 10 5 cells/mouse, s.c.) on day 0. Mice with complete tumor regression were subjected to tumor rechallenge with MC38‐OVA cells (3 × 10 6 cells/mouse, s.c.), and tumor analysis was performed on day 60. (I) Representative flow cytometry images of central T cells and memory T cells in spleen following various treatments. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (J) Flow cytometry analysis of granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 . (K and L) IFN‐𝛾 secretion by splenocytes isolated from different treatment groups, as determined using the <t>ELISPOT</t> assay after restimulation of the cells with OVA 257–264 . (M) Tumor killing ability of the splenocytes isolated T cells activated by OVA 257–264 . After 24 h co‐culture with OVA 257–264 , the T cells were co‐cultured with MC38‐OVA cells at a 3:1 ratio for 24 h, cell viability was measured by CCK‐8 assay. (N) Tumor growth curve following tumor rechallenge and Survival curves of mice under Im@NOnanoPL+αPD‐1 or PBS. ( n = 6).
Elispot Reader S6 Ultra M2, supplied by Cellular Technology Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/S6+Ultra+M2/bio_rxiv__64898__2026__03__18__712579-225-8-13
Average 99 stars, based on 1 article reviews
elispot reader s6 ultra m2 - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

99
Cellular Technology Ltd aid classic elispot plate reader
Magnitude and specificity of T cell memory responses generated by 899-day infection (A) Ex vivo <t>IFNγ-ELISpot</t> well images. DMSO control unstimulated wells and wells stimulated with overlapping peptides covering S1 and S2 region of Spike (duplicates shown), or single peptides S51 and S134. (B) Total magnitude of SARS-CoV-2-specific memory T cell response to structural proteins Spike, membrane (M), nucleoprotein (NP) and open reading frame 3a (ORF3a) and RTC proteins (NSP7, NSP12 polymerase, and NSP13 helicase) colored by protein targeted and measured after persistent infection (>900 days). (C and D) Total magnitude of SARS-CoV-2-specific T cell response (C) or T cell response to Structural and RTC proteins (D) in pre-pandemic samples (pre-August 2019), in exposed healthcare workers (HCW) who remained seronegative, including abortive infections, and in HCW with laboratory confirmed SARS-CoV-2 infections (samples 4 months post-exposure/infection in June to July 2020) for comparison to T cell response in persistently infected patient. (E) Ratio of the magnitude of the T cell response to RTC/structural T cells. Percentage of cohort with a response above 1 (stronger response to RTC than structural proteins) shown below. (F) Magnitude of T cell response to a pool of epitopes from Flu, EBV, and CMV. (B–E) Subset of data previously published in Swadling et al. (A–F) IFNγ-ELISpot. (C and D) Box and Whisker, Tukey. (C–F) Statistical analysis was performed using Kruskal-Wallis tests with Dunn’s correction. ∗ p ≤ 0.05; ∗∗ p ≤ 0.01; ∗∗∗ p ≤ 0.001; ∗∗∗∗ p < 0.0001. (E and F) Bars, geomean.
Aid Classic Elispot Plate Reader, supplied by Cellular Technology Ltd, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/S6+Universal+M2/pmc12936837-401-18-23
Average 99 stars, based on 1 article reviews
aid classic elispot plate reader - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

86
Mabtech Inc mabtech elispot reader
Magnitude and specificity of T cell memory responses generated by 899-day infection (A) Ex vivo <t>IFNγ-ELISpot</t> well images. DMSO control unstimulated wells and wells stimulated with overlapping peptides covering S1 and S2 region of Spike (duplicates shown), or single peptides S51 and S134. (B) Total magnitude of SARS-CoV-2-specific memory T cell response to structural proteins Spike, membrane (M), nucleoprotein (NP) and open reading frame 3a (ORF3a) and RTC proteins (NSP7, NSP12 polymerase, and NSP13 helicase) colored by protein targeted and measured after persistent infection (>900 days). (C and D) Total magnitude of SARS-CoV-2-specific T cell response (C) or T cell response to Structural and RTC proteins (D) in pre-pandemic samples (pre-August 2019), in exposed healthcare workers (HCW) who remained seronegative, including abortive infections, and in HCW with laboratory confirmed SARS-CoV-2 infections (samples 4 months post-exposure/infection in June to July 2020) for comparison to T cell response in persistently infected patient. (E) Ratio of the magnitude of the T cell response to RTC/structural T cells. Percentage of cohort with a response above 1 (stronger response to RTC than structural proteins) shown below. (F) Magnitude of T cell response to a pool of epitopes from Flu, EBV, and CMV. (B–E) Subset of data previously published in Swadling et al. (A–F) IFNγ-ELISpot. (C and D) Box and Whisker, Tukey. (C–F) Statistical analysis was performed using Kruskal-Wallis tests with Dunn’s correction. ∗ p ≤ 0.05; ∗∗ p ≤ 0.01; ∗∗∗ p ≤ 0.001; ∗∗∗∗ p < 0.0001. (E and F) Bars, geomean.
Mabtech Elispot Reader, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/elispot+fluorospot+iris+mabtech+reader/bio_rxiv__64898__2026__03__12__711389-106-6-9
Average 86 stars, based on 1 article reviews
mabtech elispot reader - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

86
Mabtech Inc elispot reader mabtech astortm2
Magnitude and specificity of T cell memory responses generated by 899-day infection (A) Ex vivo <t>IFNγ-ELISpot</t> well images. DMSO control unstimulated wells and wells stimulated with overlapping peptides covering S1 and S2 region of Spike (duplicates shown), or single peptides S51 and S134. (B) Total magnitude of SARS-CoV-2-specific memory T cell response to structural proteins Spike, membrane (M), nucleoprotein (NP) and open reading frame 3a (ORF3a) and RTC proteins (NSP7, NSP12 polymerase, and NSP13 helicase) colored by protein targeted and measured after persistent infection (>900 days). (C and D) Total magnitude of SARS-CoV-2-specific T cell response (C) or T cell response to Structural and RTC proteins (D) in pre-pandemic samples (pre-August 2019), in exposed healthcare workers (HCW) who remained seronegative, including abortive infections, and in HCW with laboratory confirmed SARS-CoV-2 infections (samples 4 months post-exposure/infection in June to July 2020) for comparison to T cell response in persistently infected patient. (E) Ratio of the magnitude of the T cell response to RTC/structural T cells. Percentage of cohort with a response above 1 (stronger response to RTC than structural proteins) shown below. (F) Magnitude of T cell response to a pool of epitopes from Flu, EBV, and CMV. (B–E) Subset of data previously published in Swadling et al. (A–F) IFNγ-ELISpot. (C and D) Box and Whisker, Tukey. (C–F) Statistical analysis was performed using Kruskal-Wallis tests with Dunn’s correction. ∗ p ≤ 0.05; ∗∗ p ≤ 0.01; ∗∗∗ p ≤ 0.001; ∗∗∗∗ p < 0.0001. (E and F) Bars, geomean.
Elispot Reader Mabtech Astortm2, supplied by Mabtech Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/elispot+reader/elispot+fluorospot+iris+mabtech+reader/pm41796205-146-6-8
Average 86 stars, based on 1 article reviews
elispot reader mabtech astortm2 - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

Image Search Results


Im@NOnanoPL nanovaccine mediated enhanced long‐term immune memory in vivo. (A) Schematic illustration to evaluate the therapeutic antitumor effects after different treatments. (B) Flow cytometry analysis of MHC‐I expression and MHC‐I OVA complex levels of DCs in lymph nodes (n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (C) Flow cytometry analysis of CD80 + CD86 + among CD11c + DCs in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (D) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (E) Percentage of CD69 + CD8 + T cells in spleen after 24 h co‐culture with OVA polypeptide, as detected using flow cytometry ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (F) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (G) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD4 + T cells in spleen after 24 h co‐culture with OVA polypeptide. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (H) Schema illustrating the vaccination long‐term immune memory. Mice were challenged with MC38‐OVA cells (3 × 10 5 cells/mouse, s.c.) on day 0. Mice with complete tumor regression were subjected to tumor rechallenge with MC38‐OVA cells (3 × 10 6 cells/mouse, s.c.), and tumor analysis was performed on day 60. (I) Representative flow cytometry images of central T cells and memory T cells in spleen following various treatments. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (J) Flow cytometry analysis of granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 . (K and L) IFN‐𝛾 secretion by splenocytes isolated from different treatment groups, as determined using the ELISPOT assay after restimulation of the cells with OVA 257–264 . (M) Tumor killing ability of the splenocytes isolated T cells activated by OVA 257–264 . After 24 h co‐culture with OVA 257–264 , the T cells were co‐cultured with MC38‐OVA cells at a 3:1 ratio for 24 h, cell viability was measured by CCK‐8 assay. (N) Tumor growth curve following tumor rechallenge and Survival curves of mice under Im@NOnanoPL+αPD‐1 or PBS. ( n = 6).

Journal: Exploration

Article Title: A Nitric Oxide–Based STING Agonist Nanoadjuvant With ICD‐Derived Membrane Antigens Unleashes Robust Antitumor Immunity

doi: 10.1002/exp2.70238

Figure Lengend Snippet: Im@NOnanoPL nanovaccine mediated enhanced long‐term immune memory in vivo. (A) Schematic illustration to evaluate the therapeutic antitumor effects after different treatments. (B) Flow cytometry analysis of MHC‐I expression and MHC‐I OVA complex levels of DCs in lymph nodes (n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (C) Flow cytometry analysis of CD80 + CD86 + among CD11c + DCs in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (D) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in lymph nodes ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (E) Percentage of CD69 + CD8 + T cells in spleen after 24 h co‐culture with OVA polypeptide, as detected using flow cytometry ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (F) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 ( n = 4). Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (G) Flow cytometry analysis of IFN‐γ and granzyme B expression on CD4 + T cells in spleen after 24 h co‐culture with OVA polypeptide. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (H) Schema illustrating the vaccination long‐term immune memory. Mice were challenged with MC38‐OVA cells (3 × 10 5 cells/mouse, s.c.) on day 0. Mice with complete tumor regression were subjected to tumor rechallenge with MC38‐OVA cells (3 × 10 6 cells/mouse, s.c.), and tumor analysis was performed on day 60. (I) Representative flow cytometry images of central T cells and memory T cells in spleen following various treatments. Statistical analysis was performed using one‐way ANOVA followed by Tukey's multiple comparisons test. (J) Flow cytometry analysis of granzyme B expression on CD8 + T cells in spleen after 24 h co‐culture with OVA 257–264 . (K and L) IFN‐𝛾 secretion by splenocytes isolated from different treatment groups, as determined using the ELISPOT assay after restimulation of the cells with OVA 257–264 . (M) Tumor killing ability of the splenocytes isolated T cells activated by OVA 257–264 . After 24 h co‐culture with OVA 257–264 , the T cells were co‐cultured with MC38‐OVA cells at a 3:1 ratio for 24 h, cell viability was measured by CCK‐8 assay. (N) Tumor growth curve following tumor rechallenge and Survival curves of mice under Im@NOnanoPL+αPD‐1 or PBS. ( n = 6).

Article Snippet: Air‐dried plates were analyzed using an automated ELISPOT reader (Cellular Technology Ltd), and spot counts were quantified with ImmunoSpot software.

Techniques: In Vivo, Flow Cytometry, Analysis, Expressing, Co-culture Assay, Isolation, Enzyme-linked Immunospot, Cell Culture, CCK-8 Assay

Magnitude and specificity of T cell memory responses generated by 899-day infection (A) Ex vivo IFNγ-ELISpot well images. DMSO control unstimulated wells and wells stimulated with overlapping peptides covering S1 and S2 region of Spike (duplicates shown), or single peptides S51 and S134. (B) Total magnitude of SARS-CoV-2-specific memory T cell response to structural proteins Spike, membrane (M), nucleoprotein (NP) and open reading frame 3a (ORF3a) and RTC proteins (NSP7, NSP12 polymerase, and NSP13 helicase) colored by protein targeted and measured after persistent infection (>900 days). (C and D) Total magnitude of SARS-CoV-2-specific T cell response (C) or T cell response to Structural and RTC proteins (D) in pre-pandemic samples (pre-August 2019), in exposed healthcare workers (HCW) who remained seronegative, including abortive infections, and in HCW with laboratory confirmed SARS-CoV-2 infections (samples 4 months post-exposure/infection in June to July 2020) for comparison to T cell response in persistently infected patient. (E) Ratio of the magnitude of the T cell response to RTC/structural T cells. Percentage of cohort with a response above 1 (stronger response to RTC than structural proteins) shown below. (F) Magnitude of T cell response to a pool of epitopes from Flu, EBV, and CMV. (B–E) Subset of data previously published in Swadling et al. (A–F) IFNγ-ELISpot. (C and D) Box and Whisker, Tukey. (C–F) Statistical analysis was performed using Kruskal-Wallis tests with Dunn’s correction. ∗ p ≤ 0.05; ∗∗ p ≤ 0.01; ∗∗∗ p ≤ 0.001; ∗∗∗∗ p < 0.0001. (E and F) Bars, geomean.

Journal: iScience

Article Title: Extensive evolution and T cell escape by SARS-CoV-2 in a 2.5-year persistent infection of an immunocompromised host

doi: 10.1016/j.isci.2026.114917

Figure Lengend Snippet: Magnitude and specificity of T cell memory responses generated by 899-day infection (A) Ex vivo IFNγ-ELISpot well images. DMSO control unstimulated wells and wells stimulated with overlapping peptides covering S1 and S2 region of Spike (duplicates shown), or single peptides S51 and S134. (B) Total magnitude of SARS-CoV-2-specific memory T cell response to structural proteins Spike, membrane (M), nucleoprotein (NP) and open reading frame 3a (ORF3a) and RTC proteins (NSP7, NSP12 polymerase, and NSP13 helicase) colored by protein targeted and measured after persistent infection (>900 days). (C and D) Total magnitude of SARS-CoV-2-specific T cell response (C) or T cell response to Structural and RTC proteins (D) in pre-pandemic samples (pre-August 2019), in exposed healthcare workers (HCW) who remained seronegative, including abortive infections, and in HCW with laboratory confirmed SARS-CoV-2 infections (samples 4 months post-exposure/infection in June to July 2020) for comparison to T cell response in persistently infected patient. (E) Ratio of the magnitude of the T cell response to RTC/structural T cells. Percentage of cohort with a response above 1 (stronger response to RTC than structural proteins) shown below. (F) Magnitude of T cell response to a pool of epitopes from Flu, EBV, and CMV. (B–E) Subset of data previously published in Swadling et al. (A–F) IFNγ-ELISpot. (C and D) Box and Whisker, Tukey. (C–F) Statistical analysis was performed using Kruskal-Wallis tests with Dunn’s correction. ∗ p ≤ 0.05; ∗∗ p ≤ 0.01; ∗∗∗ p ≤ 0.001; ∗∗∗∗ p < 0.0001. (E and F) Bars, geomean.

Article Snippet: Plates were washed in double-distilled H 2 O and left to dry overnight before being read on the AID classic ELISpot plate reader (Immunospot S6 Universal M2 ELISpot Reader).

Techniques: Generated, Infection, Ex Vivo, Enzyme-linked Immunospot, Control, Membrane, Comparison, Whisker Assay

Failure of host T cells to recognize emerging virus (A) Ex vivo magnitude of the T cell response to individual ancestral sequence peptides in which mutation arose over persistent infection by IFNγ-ELISpot. (B) Magnitude of the CD4 and CD8 T cell responses after 10-day in vitro peptide expansion with individual ancestral sequence peptides. Percentage of CD4 and CD8 producing IFNγ, TNF, or both are shown. (C) Magnitude of IFNγ+, IFNγ+TNF+, and CTV lo IFNγ+ CD4 and CD8 T cells after 8-day expansion with a pool of 12 peptides corresponding to ancestral sequence epitopes or variant sequence epitopes containing mutations in the virus isolated at day 899 of infection. (D) Magnitude of the IFNγ+TNF+ CD4 or CD8 T cell response after 10-day in vitro peptide stimulation with individual epitopes using ancestral sequence or variant sequence peptides for culture and re-stimulation on day 9. Summary data showing all T cell responses that were detectable (left) or shown for individual peptides (right) for CD4 then CD8 T cells. Duplicate and triplicate stimulations are shown for CD8 T cells for M14 and NSP2, respectively. (D) Bars, mean. Statistical analysis was performed using Kruskal-Wallis tests with Dunn’s correction. ∗ p ≤ 0.05; ∗∗∗ p ≤ 0.001. Peptide sequences shown in .

Journal: iScience

Article Title: Extensive evolution and T cell escape by SARS-CoV-2 in a 2.5-year persistent infection of an immunocompromised host

doi: 10.1016/j.isci.2026.114917

Figure Lengend Snippet: Failure of host T cells to recognize emerging virus (A) Ex vivo magnitude of the T cell response to individual ancestral sequence peptides in which mutation arose over persistent infection by IFNγ-ELISpot. (B) Magnitude of the CD4 and CD8 T cell responses after 10-day in vitro peptide expansion with individual ancestral sequence peptides. Percentage of CD4 and CD8 producing IFNγ, TNF, or both are shown. (C) Magnitude of IFNγ+, IFNγ+TNF+, and CTV lo IFNγ+ CD4 and CD8 T cells after 8-day expansion with a pool of 12 peptides corresponding to ancestral sequence epitopes or variant sequence epitopes containing mutations in the virus isolated at day 899 of infection. (D) Magnitude of the IFNγ+TNF+ CD4 or CD8 T cell response after 10-day in vitro peptide stimulation with individual epitopes using ancestral sequence or variant sequence peptides for culture and re-stimulation on day 9. Summary data showing all T cell responses that were detectable (left) or shown for individual peptides (right) for CD4 then CD8 T cells. Duplicate and triplicate stimulations are shown for CD8 T cells for M14 and NSP2, respectively. (D) Bars, mean. Statistical analysis was performed using Kruskal-Wallis tests with Dunn’s correction. ∗ p ≤ 0.05; ∗∗∗ p ≤ 0.001. Peptide sequences shown in .

Article Snippet: Plates were washed in double-distilled H 2 O and left to dry overnight before being read on the AID classic ELISpot plate reader (Immunospot S6 Universal M2 ELISpot Reader).

Techniques: Virus, Ex Vivo, Sequencing, Mutagenesis, Infection, Enzyme-linked Immunospot, In Vitro, Variant Assay, Isolation